Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReabold Resources Regulatory News (RBD)

Share Price Information for Reabold Resources (RBD)

Share Price is delayed by 15 minutes
Get Live Data
83.50    -0.50 (-0.60%)
Bid:
82.00
Ask:
85.00
Spread: 3.00 (3.659%)
Market Cap: £12.11m
RBD Live PriceLast checked at - London Stock Exchange

Intraday Reabold Resources Share Chart

Form 8.5 (EPT/RI) - Reabold Resources plc

24 Mar 2023 12:00

RNS Number : 1432U
Stifel Nicolaus Europe Limited
24 March 2023
Β 

FORM 8.5 (EPT/RI)

Β 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

Β 

1. KEY INFORMATION

Β 

(a) Name of exempt principal trader:

Stifel Nicolaus Europe Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Reabold Resources plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Reabold Resources plc

(d) Date dealing undertaken:

23 March 2023

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

Β 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

Β 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

Β 

The currency of all prices and other monetary amounts should be stated.

Β 

(a) Purchases and sales

Β 

Class of relevant security

Purchases/ sales

Β 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

Ordinary

Buy

350,000

0.186 GBX

0.186 GBX

Β 

(b) Cash-settled derivative transactions

Β 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

Β 

(c) Stock-settled derivative transactions (including options)

Β 

(i) Writing, selling, purchasing or varying

Β 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

Β 

(ii) Exercise

Β 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(d) Other dealings (including subscribing for new securities)

Β 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

Β 

Β 

Β 

Β 

Β 

Β 

3. OTHER INFORMATION

Β 

(a) Indemnity and other dealing arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

Β 

None

Β 

Β 

(b) Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

Β 

None

Β 

Β 

Date of disclosure:

24 March 2023

Contact name:

Danielle Homewood

Telephone number:

02034651039

Β 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.Β 

Β 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

Β 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
FERUSRWRONUOURR
Date   Source Headline
14th Mar 20184:24 pmRNSIssue of Options
2nd Mar 20186:04 pmRNSPosting of Circular
1st Mar 201811:30 amRNSIncreased Investment in Corallian Energy
28th Feb 20185:11 pmRNSResult of the Placing
28th Feb 201811:26 amRNSConditional Accelerated Bookbuild
27th Feb 201812:30 pmRNSCompany Update regarding the P2235 "Wick" Licence
26th Feb 20181:24 pmRNSStatement re Press Comment
12th Feb 20189:49 amRNSIntention to increase Corallian Energy investment
24th Jan 20185:20 pmRNSHolding(s) in Company
16th Jan 201811:16 amRNSUpdate on UK oil and gas assets
4th Dec 20177:00 amRNSInvestment in Danube Petroleum Limited
14th Nov 20177:00 amRNSPresentation at Investor Evening
1st Nov 20177:00 amRNSInvestment in UK oil and gas assets
27th Oct 20174:19 pmRNSHolding in Company
27th Oct 20179:12 amRNSHolding(s) in Company
19th Oct 20175:48 pmRNSBoard appointments and Issue of Options
16th Oct 20175:29 pmRNSHolding(s) in Company
12th Oct 201712:26 pmRNSResult of General Meeting, Issue of Equity, TVR
9th Oct 20177:00 amRNSSenior Management Appointments
2nd Oct 20174:35 pmRNSProposed subscription to raise £1.76 million
25th Sep 20173:37 pmRNSHolding(s) in Company
22nd Sep 20177:00 amRNSNotice of GM
20th Sep 20177:00 amRNSPlacing to raise £3.96m, update on strategy, TVR
19th Sep 20175:16 pmRNSHalf-year Report
14th Sep 20177:00 amRNSStmnt re Share Price Movement
16th Aug 20171:02 pmRNSResult of AGM
21st Jul 20176:02 pmRNSNotice of AGM
26th Jun 20175:44 pmRNSAnnual Report for year ended 31 December 2016
1st Jun 20178:01 amRNSInvestee company update: process metallurgy
30th May 20177:00 amRNSInvestee Company Update
25th May 20177:00 amRNSInvestee Company Update
2nd May 20174:25 pmRNSTotal Voting Rights
19th Apr 20175:45 pmRNSSubscription Completes, PDMR Shareholdings
19th Apr 20177:15 amRNSLithium-tin project investment, capital raising
28th Oct 201611:35 amRNSResult of AGM
4th Oct 20165:06 pmRNSNotice of AGM and change of registered office
29th Sep 20164:04 pmRNSHalf-year Report
2nd Aug 201611:18 amRNSDirector/PDMR Shareholding
30th Jun 20167:00 amRNSAnnual Financial Report
1st Feb 20161:41 pmRNSTotal Voting Rights
15th Jan 20161:32 pmRNSHolding(s) in Company
8th Jan 20165:45 pmRNSPlacing and Total Voting Rights
29th Sep 201512:05 pmRNSHolding(s) in Company
18th Sep 20155:35 pmRNSUnaudited Interim Results
18th Sep 20155:22 pmRNSPlacing, Total Voting Rights
5th Aug 20153:43 pmRNSResult of AGM
30th Jun 20157:00 amRNSAccounts for year ended 31 December 2014
30th Sep 20145:11 pmRNSInterim Results for 6 months to 30 June 2014
4th Sep 20144:30 pmRNSResult of Annual General Meeting
12th Aug 20145:17 pmRNSNotice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.